Pfizer Inc. (PFE) News

News for Pfizer Inc. (PFE)

Sector News | Topic News

After Hours: $ 21.00

-0.05 (-0.24%)

Volume: 832.64 k

6:23 PM EST Feb 10, 2012

Thu, Feb 09, 2012

2:19 PM

CORRECTING and REPLACING Branham Law Group Investigates Pfizer for Packaging Error Recall - Business Wire

Wed, Feb 08, 2012

8:20 AM

Blue Chip Dividend Plays Losing Appeal in 2012 - Marketwire

Tue, Feb 07, 2012

11:33 AM

Siemens Forms New Companion Diagnostics Partnerships with ViiV Healthcare and Tocagen - PR Newswire

Mon, Feb 06, 2012

3:50 PM

St. Louis-based Carey, Danis & Lowe Announces Suit Against the Maker of Zoloft - Business Wire

Fri, Feb 03, 2012

6:36 PM

Keller Rohrback L.L.P. Announces Investigation of Pfizer, Inc. Regarding the Lo/Ovral®-28 and Norgestrel Birth Control Pill Recall - Business Wire

9:00 AM

Conditions of Growth, Economic Analysis -- Research Report on Pfizer Inc. and Boston Scientific Corporation - Marketwire

Thu, Feb 02, 2012

9:00 AM

Perception, Opportunity in Volatility - Research & Analysis on Vertex Pharmaceuticals Incorporated and Pfizer Inc. - Marketwire

Wed, Feb 01, 2012

4:23 PM

Pfizer Issues Statement On Voluntary Recall - Business Wire

8:20 AM

Pfizer and GlaxoSmithKline Optimistic on Growth Prospects - Marketwire

Tue, Jan 31, 2012

7:00 AM

Pfizer Reports Fourth-Quarter and Full-Year 2011 Results; Updates 2012 Financial Guidance - Business Wire

Fri, Jan 27, 2012

1:33 PM

U.S. Food And Drug Administration Approves Pfizer's INLYTA® (axitinib) For Patients With Previously Treated Advanced Renal Cell Carcinoma (RCC) - Business Wire

8:00 AM

Pfizer Announces FDA Acceptance Of New Drug Application For Bosutinib For Patients With Previously Treated Ph+ Chronic Myeloid Leukemia - Business Wire

Thu, Jan 26, 2012

9:01 PM

Lpath Temporarily Suspends Dosing of iSONEP in Clinical Trials Due to cGMP Compliance Issues at Contract Fill/Finish Source - Marketwire

8:00 AM

Alzheimer's Challenge 2012: Seeking New Tools to Help Improve Alzheimer's Care - PR Newswire

8:00 AM

Alzheimer's Challenge 2012: Seeking New Tools To Help Improve Alzheimer's Care - Business Wire

Mon, Jan 23, 2012

4:14 PM

Acura Pharmaceuticals Provides Update on Opioid Product Licensed to Pfizer - Marketwire

Wed, Jan 18, 2012

8:20 AM

Big Pharma on the Lookout for Large Deals in 2012 - Marketwire

Tue, Jan 17, 2012

7:00 AM

Medivation and Pfizer Announce Results From Phase 3 Concert Trial of Dimebon in Alzheimer's Disease - Marketwire

7:00 AM

Medivation and Pfizer Announce Results from Phase 3 Concert Trial of Dimebon in Alzheimer's Disease - Business Wire

Thu, Jan 12, 2012

8:20 AM

General Electric and Pfizer -- Dividend Growth Plays for 2012 - Marketwire

Tue, Jan 10, 2012

8:00 AM

Introducing nutritionpossible.com - A New Resource That Offers Personalized Nutritional Guidance to Achieve Better Health - Business Wire

Tue, Jan 03, 2012

10:52 AM

Pfizer Invites Public to View and Listen to Webcast of Pfizer Presentation at Healthcare Conference - Business Wire

Mon, Jan 02, 2012

8:16 AM

Pfizer and GlaxoSmithKline Emerging From the "Good Old Days" - Marketwire

Fri, Dec 30, 2011

3:47 PM

Pfizer Receives FDA Approval to Extend Use of Prevnar 13® for Prevention of Pneumococcal Pneumonia and Invasive Disease in Adults 50 Years and Older - Business Wire

Thu, Dec 22, 2011

8:00 AM

Pfizer Reports Results From Three Phase 4 Studies Demonstrating EMBEDA® (morphine sulfate and naltrexone hydrochloride) Extended Release Capsules CII Impact On Drug Liking And Withdrawal Symptoms - Business Wire

First

1 2 3 4 5 6 7 8 9 10 11

Last